EUVIMEDEUVIMED entdecken
Crossref

A Prospective Randomized Comparative Study of Dexmedetomidine as an Adjuvant to Bupivacaine and Ropivacaine in Ultrasound-Guided Supraclavicular Brachial Plexus Block

Piu Gorai, Aathira Das, Piyush Kumar Sengar

International Journal of Pharmaceutical Quality Assurance · 30.11.2026 · 17 (11)

DOI: 10.25258/ijpqa.17.11.7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Pharmaceutical Quality Assurance, online erschienen am 30.11.2026. Verfasst von Piu Gorai und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ultrasound-guided supraclavicular brachial plexus block (SCBPB) is widely used for upper limb surgeries. Dexmedetomidine, an α2-agonist, enhances block quality when added to local anesthetics.

Aim

To compare dexmedetomidine as an adjuvant to bupivacaine versus ropivacaine in SCBPB. Methodology: In this prospective randomized study, 30 ASA I–II patients were allocated into two groups (n=15 each). Group BD received 0.5% bupivacaine + dexmedetomidine (0.5 µg/kg), while Group RD received 0.75% ropivacaine + dexmedetomidine. Onset and duration of sensory/motor block, duration of analgesia, analgesic consumption, hemodynamics, and adverse effects were assessed.

Results

Group BD showed significantly faster onset of sensory (7.4 vs 8.2 min) and motor block (10.6 vs 11.4 min). Duration of sensory (11.2 vs 10.1 h), motor block (9.1 vs 8.0 h), and analgesia (13.1 vs 11.9 h) were significantly longer in BD. Analgesic requirement was lower in BD. Side effects and satisfaction scores were comparable.

Conclusion

Dexmedetomidine enhances block characteristics with both agents; however, its combination with bupivacaine provides superior onset, prolonged analgesia, and reduced analgesic requirement without increased adverse effects.

Zitieren

APA

Gorai, P., Das, A., & Sengar, P. K. (2026). A Prospective Randomized Comparative Study of Dexmedetomidine as an Adjuvant to Bupivacaine and Ropivacaine in Ultrasound-Guided Supraclavicular Brachial Plexus Block. International Journal of Pharmaceutical Quality Assurance, 17(11). https://doi.org/10.25258/ijpqa.17.11.7

Vancouver

Gorai P, Das A, Sengar PK. A Prospective Randomized Comparative Study of Dexmedetomidine as an Adjuvant to Bupivacaine and Ropivacaine in Ultrasound-Guided Supraclavicular Brachial Plexus Block. International Journal of Pharmaceutical Quality Assurance. 2026;17(11). doi:10.25258/ijpqa.17.11.7

BibTeX
@article{Gorai2026,
  author = {Gorai, Piu and Das, Aathira and Sengar, Piyush Kumar},
  title = {A Prospective Randomized Comparative Study of Dexmedetomidine as an Adjuvant to Bupivacaine and Ropivacaine in Ultrasound-Guided Supraclavicular Brachial Plexus Block},
  journal = {International Journal of Pharmaceutical Quality Assurance},
  year = {2026},
  volume = {17},
  number = {11},
  doi = {10.25258/ijpqa.17.11.7}
}
Kostenlos starten →